Richard Greil

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 52

Top Topics

Multiple Myeloma

Squamous Cell Carcinoma

Chronic Lymphocytic Leukemia

Top Venues

International journal of molecular sciences

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Niklas Zojer, Laurenz Schöffmann, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Richard Greil
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study. EJHaem 5 (3) (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A phase 1 study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alexios Matikas, Volker Möbus, Richard Greil, Anne Andersson, Günther G Steger, Michael Untch, Tommy Fornander, Per Malmström, Sabine Schmatloch, Hemming Johansson, Mats Hellström, Yvonne Brandberg, Michael Gnant, Sibylle Loibl, Theodoros Foukakis, Jonas Bergh, null null
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Robert S Seitz, Tyler J Nielsen, Marc Thill, Antonio Antón-Torres, Stefania Russo, Eva Ciruelos Gil, Brock L Schweitzer, Douglas Teller Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Gyorffy Balazs, Marco Colleoni, Catherine M Kelly, Gabriella Mariani, Lucia Del Mastro, Olivia Blasi, Maurizio Callari, Lajos Pusztai, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Niklas Zojer, Laurenz Schöffmann, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Richard Greil
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study. EJHaem 5 (3) (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Laura Urwanisch, Michael Stefan Unger, Helene Sieberer, Hieu-Hoa Dang, Theresa Neuper, Christof Regl, Julia Vetter, Susanne Schaller, Stephan M Winkler, Emanuela Kerschbamer, Christian X Weichenberger, Peter W Krenn, Michela Luciano, Lisa Pleyer, Richard Greil, Christian G Huber, Fritz Aberger, Jutta Horejs-Hoeck
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers 15 (4) (2023)
Konstantin Schlick, Antonia Gantschnigg, Alexander Seymer, Florian Huemer, Richard Greil, Lukas Weiss
Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis. Cancer medicine (2023)
Bettina Jansko-Gadermeir, Michael Leisch, Franz Josef Gassner, Nadja Zaborsky, Thomas Dillinger, Sonja Hutter, Angela Risch, Thomas Melchardt, Alexander Egle, Manuel Drost, Julian Larcher-Senn, Richard Greil, Lisa Pleyer
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group. Cancers 15 (8) (2023)
Laura Urwanisch, Michael Stefan Unger, Helene Sieberer, Hieu-Hoa Dang, Theresa Neuper, Christof Regl, Julia Vetter, Susanne Schaller, Stephan M Winkler, Emanuela Kerschbamer, Christian X Weichenberger, Peter W Krenn, Michela Luciano, Lisa Pleyer, Richard Greil, Christian G Huber, Fritz Aberger, Jutta Horejs-Hoeck
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers 15 (4) (2023)
Lisa Pleyer, Sonja Heibl, Christoph Tinchon, Sonia Vallet, Martin Schreder, Thomas Melchardt, Norbert Stute, Kim Tamara Föhrenbach Quiroz, Michael Leisch, Alexander Egle, Lukas Scagnetti, Dominik Wolf, Richard Beswick, Manuel Drost, Julian Larcher-Senn, Thomas Grochtdreis, Marc Vaisband, Jan Hasenauer, Nadja Zaborsky, Richard Greil, Reinhard Stauder
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT. Cancers 15 (5) (2023)
Lisa Pleyer, Sonja Heibl, Christoph Tinchon, Sonia Vallet, Martin Schreder, Thomas Melchardt, Norbert Stute, Kim Tamara Föhrenbach Quiroz, Michael Leisch, Alexander Egle, Lukas Scagnetti, Dominik Wolf, Richard Beswick, Manuel Drost, Julian Larcher-Senn, Thomas Grochtdreis, Marc Vaisband, Jan Hasenauer, Nadja Zaborsky, Richard Greil, Reinhard Stauder
Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT. Cancers 15 (5) (2023)
Bettina Jansko-Gadermeir, Michael Leisch, Franz Josef Gassner, Nadja Zaborsky, Thomas Dillinger, Sonja Hutter, Angela Risch, Thomas Melchardt, Alexander Egle, Manuel Drost, Julian Larcher-Senn, Richard Greil, Lisa Pleyer
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group. Cancers 15 (8) (2023)
Laura Urwanisch, Michael Stefan Unger, Helene Sieberer, Hieu-Hoa Dang, Theresa Neuper, Christof Regl, Julia Vetter, Susanne Schaller, Stephan M Winkler, Emanuela Kerschbamer, Christian X Weichenberger, Peter W Krenn, Michela Luciano, Lisa Pleyer, Richard Greil, Christian G Huber, Fritz Aberger, Jutta Horejs-Hoeck
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers 15 (4) (2023)
Ronald Heregger, Florian Huemer, Markus Steiner, Alejandra Gonzalez-Martinez, Richard Greil, Lukas Weiss
Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer. Cancers 15 (20) (2023)
Michael Leisch, Michael Pfeilstöcker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Christoph Tinchon, Bernd Hartmann, Andreas Petzer, Martin Schreder, David Kiesl, Sonia Vallet, Alexander Egle, Thomas Melchardt, Gudrun Piringer, Armin Zebisch, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Manuel Drost, Richard Greil, Lisa Pleyer
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group. Cancers 14 (10) (2022)
Kevin J Harrington, Barbara A Burtness, Richard Greil, Denis Soulieres, Makato Tahara, Gilberto de Castro Junior, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Jianxin Lin, Burak Gumuscu, Ramona F Swaby, Danny Rischin
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Barbara A Burtness, Danny Rischin, Richard Greil, Denis Soulieres, Makato Tahara, Gilberto de Castro Junior, Amanda Psyrri, Irene Brana, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Joy Ge, Ramona F Swaby, Burak Gumuscu, Kevin J Harrington
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Barbara Mayr, Bernhard Reich, Richard Greil, Josef Niebauer
The effect of exercise training on endothelial function in postmenopausal women with breast cancer under aromatase inhibitor therapy. Cancer medicine (2022)
Ekaterina Akimova, Franz Josef Gassner, Richard Greil, Nadja Zaborsky, Roland Geisberger
Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia. International journal of molecular sciences 23 (3) (2022)
Dominik Kiem, Michael Leisch, Daniel Neureiter, Theresa Haslauer, Alexander Egle, Thomas Melchardt, Max S Topp, Richard Greil
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy. International journal of molecular sciences 22 (11) (2021)
Maria Orfanoudaki, Anja Hartmann, Mostafa Alilou, Naida Mehic, Marcel Kwiatkowski, Karin Jöhrer, Huu Tung Nguyen, Andreas Hensel, Richard Greil, Markus Ganzera
Cytotoxic Compounds of Two Demosponges (Aplysina aerophoba and Spongia sp.) from the Aegean Sea. Biomolecules 11 (5) (2021)
Dominik Kiem, Sandro Wagner, Teresa Magnes, Alexander Egle, Richard Greil, Thomas Melchardt
The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative Neoplasms. International journal of molecular sciences 22 (17) (2021)
Teresa Magnes, Sandro Wagner, Dominik Kiem, Lukas Weiss, Gabriel Rinnerthaler, Richard Greil, Thomas Melchardt
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 22 (9) (2021)
Michael Gnant, Amylou C Dueck, Sophie Frantal, Miguel Martin, Hal J Burstein, Richard Greil, Peter Fox, Antonio C Wolff, Arlene Chan, Eric P Winer, Georg Pfeiler, Kathy D Miller, Marco Colleoni, Jennifer M Suga, Gabor Rubovszky, Judith M Bliss, Ingrid A Mayer, Christian F Singer, Zbigniew Nowecki, Olwen Hahn, Jacqui Thomson, Norman Wolmark, Kepa Amillano, Hope S Rugo, Guenther G Steger, Blanca Hernando Fernández de Aránguiz, Tufia C Haddad, Antonia Perelló, Meritxell Bellet, Hannes Fohler, Otto Metzger Filho, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, Kathy P Theall, Dongrui Ray Lu, Kathleen Tenner, Christian Fesl, Angela M DeMichele, Erica L Mayer, null null
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Konstantin Schlick, Dominik Kiem, Richard Greil
Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature. Biomolecules 11 (10) (2021)
Florian Huemer, Michael Leisch, Roland Geisberger, Nadja Zaborsky, Richard Greil
miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Simon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon, Andreas Petzer, Marija Balic, Sonja Heibl, Clemens Schmitt, August Felix Zabernigg, Daniel Egle, Margit Sandholzer, Christian Fridolin Singer, Florian Roitner, Christopher Hager, Johannes Andel, Michael Hubalek, Michael Knauer, Richard Greil
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry. Breast cancer research : BCR 23 (1) (2021)
Teresa Magnes, Sandro Wagner, Aaron R Thorner, Daniel Neureiter, Eckhard Klieser, Gabriel Rinnerthaler, Lukas Weiss, Florian Huemer, Konstantin Schlick, Nadja Zaborsky, Markus Steiner, Richard Greil, Alexander Egle, Thomas Melchardt
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies. Cancers 13 (4) (2021)
J Randolph Hecht, Sara Lonardi, Johanna Bendell, Hao-Wen Sim, Teresa Macarulla, Charles D Lopez, Eric Van Cutsem, Andrés Muñoz Martin, Joon Oh Park, Richard Greil, Hong Wang, Rebecca R Hozak, Ivelina Gueorguieva, Yong Lin, Sujata Rao, Baek-Yeol Ryoo
Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Theresa Haslauer, Richard Greil, Nadja Zaborsky, Roland Geisberger
CAR T-Cell Therapy in Hematological Malignancies. International journal of molecular sciences 22 (16) (2021)
Thomas Parigger, Franz Josef Gassner, Christian Scherhäufl, Aryunni Abu Bakar, Jan Philip Höpner, Alexandra Hödlmoser, Markus Steiner, Kemal Catakovic, Roland Geisberger, Richard Greil, Nadja Zaborsky
Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia. International journal of molecular sciences 22 (13) (2021)
Markus Steiner, Franz Josef Gassner, Thomas Parigger, Daniel Neureiter, Alexander Egle, Roland Geisberger, Richard Greil, Nadja Zaborsky
A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report. International journal of molecular sciences 22 (17) (2021)
David Lang, Anna Brauner, Florian Huemer, Gabriel Rinnerthaler, Andreas Horner, Romana Wass, Elmar Brehm, Bernhard Kaiser, Richard Greil, Bernd Lamprecht
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study. Cancers 14 (1) (2021)
Heide-Marie Binder, Nicole Maeding, Martin Wolf, André Cronemberger Andrade, Balazs Vari, Linda Krisch, Fausto Gueths Gomes, Constantin Blöchl, Katharina Muigg, Rodolphe Poupardin, Anna M Raninger, Thomas Heuser, Astrid Obermayer, Patricia Ebner-Peking, Lisa Pleyer, Richard Greil, Christian G Huber, Katharina Schallmoser, Dirk Strunk
Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles. Cells 10 (12) (2021)
Maria Schubert, Franz Josef Gassner, Michael Huemer, Jan Philip Höpner, Ekaterina Akimova, Markus Steiner, Alexander Egle, Richard Greil, Nadja Zaborsky, Roland Geisberger
AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL. Cancers 13 (11) (2021)
Teresa Magnes, Sandro M Wagner, Thomas Melchardt, Lukas Weiss, Gabriel Rinnerthaler, Florian Huemer, Michael Kopp, Simon Peter Gampenrieder, Beate Mayrbäurl, Thorsten Füreder, Daniel Lenger, Johannes Andel, Alexander Egle, Richard Greil
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT. Wiener klinische Wochenschrift 133 (21-22) (2021)
Heinz Ludwig, Bela Hausmann, Martin Schreder, Wolfram Pönisch, Niklas Zojer, Stefan Knop, Eberhard Gunsilius, Alexander Egle, Andreas Petzer, Hermann Einsele, Roman Hájek, Katja Weisel, Karl Jochen Krenosz, Alois Lang, Daniel Lechner, Richard Greil, David Berry
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial). EJHaem 2 (1) (2020)
Fiorenza Barraco, Richard Greil, Raoul Herbrecht, Burkhard Schmidt, Andreas Reiter, Wolfgang Willenbacher, Reinier Raymakers, Rüdiger Liersch, Monika Wroclawska, Robert Pack, Karin Burock, Divyadeep Karumanchi, Heinz Gisslinger
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis. British journal of haematology 191 (5) (2020)
Florian Huemer, Gudrun Piringer, Verena Schlintl, Hubert Hackl, Gabriel Rinnerthaler, Josef Thaler, Richard Greil, Lukas Weiss
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy. Cancers 12 (10) (2020)
Franz J Gassner, Nadja Zaborsky, Daniel Feldbacher, Richard Greil, Roland Geisberger
RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia. Cancers 12 (5) (2020)
Florian Huemer, Eckhard Klieser, Daniel Neureiter, Verena Schlintl, Gabriel Rinnerthaler, Franck Pagès, Amos Kirilovsky, Carine El Sissy, Wolfgang Iglseder, Franz Xaver Singhartinger, Tarkan Jäger, Adam Dinnewitzer, Nadja Zaborsky, Markus Steiner, Richard Greil, Lukas Weiss
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy. Journal of clinical medicine 9 (9) (2020)
Florian Huemer, Michael Leisch, Roland Geisberger, Thomas Melchardt, Gabriel Rinnerthaler, Nadja Zaborsky, Richard Greil
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence. International journal of molecular sciences 21 (8) (2020)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, Markus Steiner, Claudia Monzo-Fuentes, Thomas Melchardt, Teresa Magnes, Florian Huemer, Theresa Westphal, Clemens Hufnagl, Cornelia Hauser-Kronberger, Alexander Egle, Richard Greil
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial. Journal of clinical medicine 9 (6) (2020)
Johanna Willer, Karin Jöhrer, Richard Greil, Christian Zidorn, Serhat Sezai Çiçek
Cytotoxic Properties of Damiana (Turnera diffusa) Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay. Molecules (Basel, Switzerland) 24 (5) (2019)
Antroula Papakonstantinou, Alexios Matikas, Nils Olof Bengtsson, Per Malmström, Elham Hedayati, Guenther Steger, Michael Untch, Laila Hübbert, Hemming Johansson, Mats Hellström, Michael Gnant, Sibylle Loibl, Richard Greil, Volker Moebus, Theodoros Foukakis, Jonas Bergh
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trial. Cancer 126 (6) (2019)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Richard Greil
HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer. International journal of molecular sciences 20 (5) (2019)
Florian Huemer, David Lang, Theresa Westphal, Simon Peter Gampenrieder, Georg Hutarew, Lukas Weiss, Hubert Hackl, Bernd Lamprecht, Gabriel Rinnerthaler, Richard Greil
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade. Journal of clinical medicine 8 (7) (2019)
Alexander Egle, Thomas Melchardt, Petra Obrtlíková, Lukáš Smolej, Tomáš Kozák, Michael Steurer, Johannes Andel, Sonja Burgstaller, Eva Mikušková, Liana Gercheva, Thomas Nösslinger, Tomáš Papajík, Miriam Ladická, Michael Girschikofsky, Mikuláš Hrubiško, Ulrich Jäger, Daniela Voskova, Martin Pecherstorfer, Eva Králiková, Christina Burcoveanu, Emil Spasov, Andreas Petzer, Georgi Mihaylov, Julian Raynov, Horst Oexle, August Zabernigg, Emília Flochová, Stanislav Palášthy, Olga Stehlíková, Michael Doubek, Petra Altenhofer, Lukas Weiss, Teresa Magnes, Lisa Pleyer, Anton Klingler, Jiří Mayer, Richard Greil
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. Cancer medicine 8 (4) (2019)
Theresa Westphal, Gabriel Rinnerthaler, Simon Peter Gampenrieder, Josef Niebauer, Josef Thaler, Michael Pfob, David Fuchs, Marina Riedmann, Barbara Mayr, Bernhard Reich, Thomas Melchardt, Brigitte Mlineritsch, Lisa Pleyer, Richard Greil
Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial. Cancer medicine 7 (12) (2018)
Richard Greil, Sigrun Greil-Ressler, Lukas Weiss, Charlotte Schönlieb, Teresa Magnes, Bianca Radl, Gordon T Bolger, Brigitta Vcelar, Peter P Sordillo
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer. Cancer chemotherapy and pharmacology 82 (4) (2018)